Clinical Study Data Request Registered Users, Please Login

Find by:

Study ID:
Medicine:
Phase:

Study to evaluate immunogenicity and safety of three production lots of GSK Biologicals' combined MeMuRu-OKA candidate vaccine given on a two-dose schedule to healthy children, as compared to separate administration of GSK Biologicals' Priorix® and Varilrix® vaccines
Combined Measles, Mumps, Rubella, Varicella Vaccine
208136/040
Measles; Mumps; Rubella; Varicella
Phase 3
 
This is a Year 2 follow up study to 208136/038. An annotated case report form is not available for this study. A blank case report form will be provided. A link to Clinicaltrials.gov and a NCT ID number are not available for this study because the study was conducted before regulatory requirements to register studies.
February 2015

Powered by ideaPoint, Inc.